Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

Simona Di Giambenedetto

Risultato della ricerca: Contributo in rivista › Articolo in rivista

4 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology